Skip to main content

Table 2 Australian and NZ studies reporting adverse events from surgery involving patients with colorectal cancer

From: Potential hospital cost-savings attributed to improvements in outcomes for colorectal cancer surgery following self-audit

Author, Year & No. cases

% elective cases

% anastomotic leak (AL)

% wound infection

% DVT

% return to theatre

% respiratory

% 30-day deaths

Semmens 2000 [16] n = 9,673

77%

6.5%

8.3% post-op infect

ns

Most of AL (est.5%)

ns

4.2%

Birks 2001 [15]

n = 877

69%

3.3%

7.2%

ns

5.7%

ns

4.1% CRC patients

Kable 2002 [17]

n = 5,432

ns

ns

2.1%

0.3%

ns

pneumonia 0.2%

0.8%

Killingback 2002 [19] n = 1,418

100%

4.1%

2.1%

1.1%

2.7%

6.7% (incl various)

1.6%

McGrath 2004 [10, 11] & 2005

n = 1,911

86-93%

0.0-3.0%

6.6-9.1%

1.0-6.7%

ns

0-1.6% pulmonary embolism

4.0-4.3%

Wong 2005 [30]

n = 1,293

83%

0.5-1.1%

4.2-7.8%

2.3-3.9%

2.7-6.7%

ns

1.2-7.7%

Gollop 2006 [13]

n = 170

71%

3%

Ns

ns

12%

ns

5%

Samson 2007 [14]

n = 191

ns

4.5%

11%

ns

7%

ns

4%

O'Grady 2007 [12]

n = 133

91%

4.7%

22%

ns

3%

7.5%

0.8%

Bowles 2007 [4]

n = 500 pre

n = 100 post

63%

Pre 8.2%

Post 1.4%

Ns

ns

Pre 12.2%

Post 5%

ns

Pre 6.38%

Post 0%

Frye 2009 [18]

n = 1,513

100%

3.8%

Ns

ns

ns

ns

0.2%

SUMMARY1

low-high values

 

0.5-8.2%

2.1-9.1%

0.3-6.7%

2.7-12.2%

0.2-10.7%

0.2-7.7%

  1. (Abbreviations: ns = not stated, DVT = deep vein thrombosis, AL = anastomotic leak, CRC = colorectal cancer)
  2. 1. Summary rates exclude 0% where reported and 22.3% wound infection rate from O'Grady 2007 that was considered an outlier and possibly due to inclusion of superficial and deep infections.